Depletion of Amyloid Precursor Protein (APP) Causes G0 Arrest in Non-Small Cell Lung Cancer (NSCLC) Cells

Journal of Cellular Physiology

Volumn 230, Issue 6, 2015, Pages 1332-1341

  Sobol, Anna ^a   Galluzzo, Paola ^a   Weber, Megan J ^a   Alani, Sara ^a   Bocchetta, Maurizio ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYCLIN C; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE 8; GAMMA SECRETASE; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; METHIONINE; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RNA POLYMERASE II; UBIQUITIN; APP PROTEIN, HUMAN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL PERMEABILIZATION; CELL PROLIFERATION; CELL SIZE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROBLAST; MOLECULAR WEIGHT; NON SMALL CELL LUNG CANCER; NUTRIENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STEADY STATE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; CELL CYCLE G1 PHASE; GENETICS; LUNG TUMOR; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

AMYLOID BETA-PROTEIN PRECURSOR; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; G0 PHASE; G1 PHASE; HUMANS; LUNG NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84923265973     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24875     Document Type: Article

References (43)

1. Ausserlechner MJ, Obexer P, Geley S, Kofler R. 2005. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression. Leukemia 19:1051-1057.
2. Böhni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E. 1996. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IR S1-4. Cell 97:865-875.
3. Baxter GC, Stanners CP. 1978. The effect of protein degradation on cellular growth characteristics. J Cell Physiol 96:139-145.
4. Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, Nellist M, Gamble V, Harris PC, Sampson JR. 1994. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-a contiguous gene syndrome. Nat Genet 8:328-332.
5. Cao X, Südhof TC. 2004. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 279:24601-24611.
6. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L, Bocchetta M. 2007. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res 67:7954-7959.
7. Conlon IJ, Dunn GA, Mudge AW, Raff MC. 2001. Extracellular control of cell size. Nat Cell Biol 3:918-921.
8. Dang CV. 2011. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harb Symp Quant Biol 76:369-374.
9. Dolznig H, Grebien F, Sauer T, Beug H, Müllner EW. 2004. Evidence for a size-sensing mechanism in animal cells. Nat Cell Biol 6:899-905.
10. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI. 2010. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142:857-867.
11. Dummler B, Tschopp O, Hynx D, Yang ZZ, Dirnhofer S, Hemmings BA. 2006. Life with a single isoform of Akt: Mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 26:8042-8051.
12. Echave P, Conlon IJ, Lloyd AC. 2007. Cell size regulation in mammalian cells. Cell Cycle 62:218-224.
13. Ekholm SV, Zickert P, Reed SI, Zetterberg A. 2001. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol Cell Biol 21:3256-3265.
14. Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha S, Miele L, Bocchetta M. 2010. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene 29:2488-2498.
15. Fingar DC, Blenis J. 2004. Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171.
16. Goberdhan DC, Paricio N, Goodman EC, Mlodzik M, Wilson C. 1999. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev 13:3244-3258.
17. Höckel M, Vaupel P. 2001. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266-276.
18. Hautbergue G, Goguel V. 1999. The yeast C-type cyclin Ctk2p is phosphorylated and rapidly degraded by the ubiquitin-proteasome pathway. Mol Cell Biol 19:2527-2534.
19. Ho A, Dowdy SF. 2002. Regulation of G91) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Devel 12:47-52.
20. Kim W1, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP. 2011. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44:325-340.
21. Kyle AH, Baker JH, Minchinton AI. 2012. Targeting quiescent tumor cells via oxygen and IGF-I supplementation. Cancer Res 72:801-809.
22. Laplante M, Sabatini DM. 2012. MTOR signaling in growth control and disease. Cell 149:274-293.
23. Leevers SJ, Weinkove D, MacDougall LK, Hafen E, Waterfield MD. 1996. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J 15:6584-6594.
24. Liang S, Galluzzo P, Sobol A, Skucha S, Rambo B, Bocchetta M. 2012. Multimodality approaches to treat hypoxic Non-Small Cell Lung Cancer (NSCLC) microenvironment. Genes Cancer 3:141-151.
25. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67.
26. Lindqvist LM, Vikström I, Chambers JM, McArthur K, Ann Anderson, Henley M, Happo KJ, Cluse L, Johnstone L, Roberts RW, Kile AW, Croker BT, Burns BA, Rizzacasa CJ, Strasser MA, Huang A. 2012. Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor. Cell Death Dis 3:409.
27. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
28. Müller UC, Zheng H. 2012. Physiological functions of APP family proteins. Cold Spring Harb Perspect Med 2:a006288.
29. Nizzari M, Venezia V, Repetto E, Caorsi V, Magrassi R, Gagliani MC, Carlo P, Florio T, Schettini G, Tacchetti C, Russo T, Diaspro A, Russo C. 2007. Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1, 2 signaling. J Biol Chem 282:13833-13844.
30. Palmer GM, Fontanella AN, Zhang G, Hanna G, Fraser CL, Dewhirst MW. 2010. Optical imaging of tumor hypoxia dynamics. J Biomed Opt 15:066021.
31. Pardee AB. 1974. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71:1286-1290.
32. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN, Sabatini DM. 2011. MTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146:408-420.
33. Ren S, Rollins BJ. 2004. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 117:239-251.
34. Rickert P, Seghezzi W, Shanahan F, Cho H, Lees E. 1996. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 12:2631-2640.
35. Ruggero D, Pandolfi PP. 2003. Does the ribosome translate cancer. Nat Rev Cancer 3:179-192.
36. Russo C, Dolcini V, Salis S, Venezia V, Zambrano N, Russo T, Schettini G. 2002. Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J Biol Chem 277:35282-35288.
37. Schutte B, Nieland L, van Engeland M, Henfling ME, Meijer L, Ramaekers FC. 1997. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics. Exp Cell Res 236:4-15.
38. Sluder G, Miller FJ, Cole R, Rieder CL. 1990. Protein synthesis and the cell cycle: centrosome reproduction in sea urchin eggs is not under translational control. J Cell Biol 110:2025-2032.
39. Sobol A, Galluzzo P, Liang S, Rambo B, Skucha S, Weber MJ, Alani S, Bocchetta M. 2014. Amyloid Precursor Protein (APP) Affects Global Protein Synthesis in Dividing Human Cells. J Cell Physiol. DOI:10.1002/jcp.24835. [Epub ahead of print].
40. Usui T, Yoshida M, Abe K, Osada H, Isono K, Beppu T. 1991. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J Cell Biol. 115:1275-1282.
41. Yasutis KM, Kozminski KG. 2013. Cell cycle checkpoint regulators reach a zillion. Cell Cycle 12:1501-1509.
42. Zetterberg A, Larsson O, Wiman KG. 1995. What is the restriction point. Curr Opin Cell Biol 7:835-842.
43. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens KA, Slunt HH, Sisoda SS, Chen HY, Van der Ploeg LH. 1995. Beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81:525-531.